[go: up one dir, main page]

NO983437L - Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike - Google Patents

Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike

Info

Publication number
NO983437L
NO983437L NO983437A NO983437A NO983437L NO 983437 L NO983437 L NO 983437L NO 983437 A NO983437 A NO 983437A NO 983437 A NO983437 A NO 983437A NO 983437 L NO983437 L NO 983437L
Authority
NO
Norway
Prior art keywords
administration
immediate
well
release forms
making
Prior art date
Application number
NO983437A
Other languages
English (en)
Other versions
NO323625B1 (no
NO983437D0 (no
Inventor
Rolf-Dieter Gabel
Alexander Wirl
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO983437D0 publication Critical patent/NO983437D0/no
Publication of NO983437L publication Critical patent/NO983437L/no
Publication of NO323625B1 publication Critical patent/NO323625B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO19983437A 1996-01-26 1998-07-24 Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmate for fremstilling av slike NO323625B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602757A DE19602757A1 (de) 1996-01-26 1996-01-26 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
PCT/EP1997/000329 WO1997026867A2 (de) 1996-01-26 1997-01-24 Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO983437D0 NO983437D0 (no) 1998-07-24
NO983437L true NO983437L (no) 1998-09-28
NO323625B1 NO323625B1 (no) 2007-06-18

Family

ID=7783738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983437A NO323625B1 (no) 1996-01-26 1998-07-24 Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmate for fremstilling av slike

Country Status (21)

Country Link
US (1) US6521262B2 (no)
EP (1) EP0877605B1 (no)
JP (1) JP2000506512A (no)
KR (1) KR19990082039A (no)
CN (1) CN1214629A (no)
AT (1) ATE226065T1 (no)
AU (1) AU717456B2 (no)
BR (1) BR9707083A (no)
CA (1) CA2243964A1 (no)
CZ (1) CZ298897B6 (no)
DE (2) DE19602757A1 (no)
ES (1) ES2184987T3 (no)
HU (1) HU224953B1 (no)
IL (1) IL125474A (no)
MX (1) MX9805939A (no)
NO (1) NO323625B1 (no)
NZ (1) NZ331051A (no)
PL (1) PL328157A1 (no)
RU (1) RU2175547C2 (no)
WO (1) WO1997026867A2 (no)
ZA (1) ZA97596B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
RU2338753C2 (ru) * 2002-03-26 2008-11-20 Новартис Вэксинес Энд Дайэгностикс С.Р.Л. Модифицированные сахариды, имеющие улучшенную стабильность в воде
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
SI1500390T1 (sl) * 2003-07-25 2006-02-28 Ferring Bv Farmacevtski dezmopresinski sestavek kot trdna dozirna oblika in postopek za njegovo pripravo
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
GB0323103D0 (en) * 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
EA011039B1 (ru) 2004-12-30 2008-12-30 Медивир Аб Приемлемые для лечения вич соединения
RU2311916C2 (ru) * 2005-09-27 2007-12-10 Галина Михайловна Сафонова Средство, обладающее антианемическим, иммуномодулирующим, адаптогенным действием (варианты)
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters
US4622392A (en) * 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel

Also Published As

Publication number Publication date
KR19990082039A (ko) 1999-11-15
WO1997026867A3 (de) 1997-09-25
HU224953B1 (en) 2006-04-28
AU717456B2 (en) 2000-03-23
NZ331051A (en) 2000-01-28
HUP9902415A3 (en) 1999-12-28
WO1997026867A2 (de) 1997-07-31
MX9805939A (es) 1998-11-30
ES2184987T3 (es) 2003-04-16
AU1594897A (en) 1997-08-20
CZ232098A3 (cs) 1998-10-14
DE59708495D1 (de) 2002-11-21
US6521262B2 (en) 2003-02-18
CZ298897B6 (cs) 2008-03-05
NO323625B1 (no) 2007-06-18
PL328157A1 (en) 1999-01-18
IL125474A0 (en) 1999-03-12
IL125474A (en) 2001-12-23
BR9707083A (pt) 1999-03-23
HUP9902415A2 (hu) 1999-11-29
CN1214629A (zh) 1999-04-21
US20020122817A1 (en) 2002-09-05
JP2000506512A (ja) 2000-05-30
ZA97596B (en) 1998-07-24
EP0877605A2 (de) 1998-11-18
RU2175547C2 (ru) 2001-11-10
DE19602757A1 (de) 1997-07-31
CA2243964A1 (en) 1997-07-31
EP0877605B1 (de) 2002-10-16
NO983437D0 (no) 1998-07-24
ATE226065T1 (de) 2002-11-15

Similar Documents

Publication Publication Date Title
NO983437L (no) Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
ATE226205T1 (de) Verbindungen
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
WO2003066661A3 (en) Human dr4 antibodies and uses thereof
DE69905368D1 (en) Oxydiertes thymosin beta 4
AU4155897A (en) Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
SI1765337T1 (sl) Kombinacija tenofovirja, ritonavirja in TMC114
IT1270618B (it) Proteine ad attivita' antitumorale
ATE187890T1 (de) Ligandgerichtete enzyme-prodrug therapie
BR0010521A (pt) Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação
WO2000042987A8 (en) Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DK1231908T3 (da) Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf
CY1106306T1 (el) Παραγωγα 5-ιμινο-13-δεοξυ ανθρακυκλινης, οι χρησεις τους και διepγασιες παρασκευης αυτων
ATE443695T1 (de) Doppelester
ES8401320A1 (es) "un procedimiento para preparar composiciones farmaceuticas a base de sales de teofilina y aminoacidos basicos".
SE9803277D0 (sv) Novel compounds